Development of antibody arrays for monoclonal antibody higher order structure analysis

Frontiers in Pharmacology

Volumn 4 AUG, Issue , 2013, Pages

  Wang, Xing ^a   Li, Qing ^a   Davies, Michael ^a  

^a Array Bridge Inc   (United States)

Author keywords

Biosimilars; Comparability; Conformational stability; ELISA; Higher order structure; Monoclonal antibody

Indexed keywords

BEVACIZUMAB; BIOSIMILAR AGENT; EPITOPE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TRASTUZUMAB;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ARTICLE; CROSS REACTION; DEAMINATION; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GLYCOSYLATION; IMMUNOGENICITY; MONOCLONAL ANTIBODY ARRAY; OXIDATION; PROTEIN CONFORMATION; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

EID: 84883543431     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00103     Document Type: Article

References (25)

1. Dyson, H. J., and Wright, P. E. (1991). Defining solution conformations of small linear peptides. Annu. Rev. Biophys. Biophys. Chem. 20, 519-538. doi: 10.1146/annurev.bb.20.060191.002511
2. Dyson, H. J., and Wright, P. E. (1993). Peptide conformation and protein folding. Curr. Biol. 3, 60-65. doi: 10.1016/0959-440X(93)90203-W
3. Franco, O. L. (2011). Peptide promiscuity: an evolutionary concept for plant defense. FEBS Lett. 585, 995-1000. doi: 10.1016/j.febslet.2011.03.008
4. Hermeling, S., Aranha, L., Damen, J. M. A., Slijper, M., Schellekens, H., Crommelin, D. J. A., et al. (2005). Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b. Pharm. Res. 22, 1997-2006. doi: 10.1007/s11095-005-8177-9
5. Hermeling, S., Crommelin, D. J. A., Schellekens, H., and Jiskoot, W. (2004). Structure-immunogenicity relationships of therapeutic proteins. Pharm. Res. 21, 897-903. doi: 10.1023/B:PHAM.0000029275.41323.a6
6. Houde, D., Arndt, J., Domeier, W., Berkowitz, S. A., and Engen, J. R. (2009). Characterization of IgG1 conformation and conformational dynamics by Hydrogen/Deuterium Exchange Mass Spectrometry. Anal. Chem. 81, 2644-2651. doi: 10.1021/ac802575y
7. Houde, D., Berkowitz, S. A., and Engen, J. R. (2011). The utility of Hydrogen/Deuterium Exchange Mass Spectrometry in biopharmaceutical comparability studies. J. Pharm. Sci. 6, 2071-2080. doi: 10.1002/jps.22432
8. Houde, D., Peng, Y., Berkowitz, S. A., and Engen, J. R. (2010). Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol. Cell Proteomics 9, 1716-1728. doi: 10.1074/mcp.M900540-MCP200
9. Jacob, R. E., and Engen, J. R. (2012). Hydrogen Exchange Mass Spectrometry: are we out of the quickland? J. Am. Soc. Mass Spectrom. 23, 1003-1010. doi: 10.1007/s13361-012-0377-z
10. James, L. C., Roversi, P., and Tawfik, D. S. (2003). Antibody multispcificity mediated by conformational diversity. Science 299, 1362-1367. doi: 10.1126/science.1079731
11. Jiskoot, W., Van Schie, R. M. F., Carstens, M. G., and Schellekens, H. (2009). Immunological risk of injectable drug delivery systems. Pharm. Res. 26, 1303-1314. doi: 10.1007/s11095-009-9855-9
12. Kaiser, E. T., and Kezdy, F. J. (1983). Secondary structures of proteins and peptides in amphiphilic environments (A Review). Proc. Natl. Acad. Sci. U.S.A. 80, 1137-1143. doi: 10.1073/pnas.80.4.1137
13. Klein, M., Haeffner-Cavaillon, N., Isenman, D. E., Rivat, C., Navia, M. A., Davies, D. R., et al. (1981). Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc. Natl. Acad. Sci. U.S.A. 78, 524-528. doi: 10.1073/pnas.78.1.524
14. Maupetit, J., Derreumaux, P., and Tuffery, P. (2009). PEP-FOLD: an online resource for de novo peptide structure prediction. Nucleic Acids Res. 37, 498-503. doi: 10.1093/nar/gkp323
15. Nestor, J. J. (2009). The medicinal chemistry of peptides. Curr. Med. Chem. 16, 4399-4418. doi: 10.2174/092986709789712907
16. Nobeli, I., Favia, A. D., and Thornton, J. M. (2009). Protein promiscuity and its implications for biotechnology. Nat. Biotechnol. 27, 157-167. doi: 10.1038/nbt1519
17. Pascal, B. D., Willis, S., Lauer, J. L., Landgraf, R. R., West, G. M., Marciano, D., et al. (2012). HDX workbench: software for the analysis of H/D Exchange MS data. J. Am. Soc. Mass Spectrom. 23, 1512-1521. doi: 10.1007/s13361-012-0419-6
18. Shon, D.-H., Enomoto, A., Yamauchi, K., and Kaminogawa, S. (1991). Antibodies raised against peptide fragments of bovine as1-casein cross-react with native protein, but recognize sites distinct from the determinants on the protein. Eur. J. Immunol. 21, 1475-1480. doi: 10.1002/eji.1830210622
19. Sominskaya, I., Pushko, P., Dreilina, D., Kozlovskaya, T., and Pumpen, P. (1992). Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes. Med. Microbiol. Immunol. 181, 215-226. doi: 10.1007/BF00215767
20. Thomas, A., Deshayes, S., Decaffmeyer, M., Van Eyck, M. H., Charloteaux, B., and Brasseur, R. (2006). Prediction of peptide structure: how far are we. Proteins Struct. Funct. Bioinformatics. 65, 889-897. doi: 10.1002/prot.21151
21. US Food and Drug Administration. (2012). Draft guidance for industry on quality considerations in demonstrating biosimilarity to a reference protein product. Fed. Regist. 77, 8883-8884.
22. Wang, X., Das, T. K., Singh, S. K., and Kumar, S. (2009). Potential aggregation prone regions in biotherapeutics. MAbs. 1, 254-267. doi: 10.4161/mabs.1.3.8035
23. Wei, H., Ahn, J., Yu, Y.-Q., Tymiak, A., and Engen, J. R. (2012). Using Hydrogen/Deuterium Exchange Mass Spectrometry to study conformational changes in Granulacyte colony stimulating factor upon PEGylation. J. Am. Soc. Mass Spectrom. 23, 498-504. doi: 10.1007/s13361-011-0310-x
24. Xiong, X.-C., Xu, W., Eberlin, L. S., Wiseman, J. M., Fang, X., Jiang, Y., et al. (2012). Data processing for 3D mass spectrometry imaging. J. Am. Soc. Mass Spectrom. 23, 1147-1150. doi: 10.1007/s13361-012-0361-7
25. Zichel, R., Chearwae, W., Pandey, G. S., Golding, B., and Sauna, Z. S. (2012). Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins. PLoS ONE 7:e31948. doi: 10.1371/journal.pone.0031948